Providers

Dr. Boruta was born and raised on the shore of Lake Michigan.

He graduated magna cum laude with both his B.S. in Biology and his M.D. degree from the University of Michigan.

As a resident in Obstetrics and Gynecology at the combined Brigham and Women's/Massachusetts General Hospital Residency Program he was elected Administrative Chief Resident. Following completion of fellowship training in Gynecologic Oncology at the University of North Carolina, Chapel Hill, he was a faculty member at the Medical College of Wisconsin in Milwaukee.

In 2008, he returned to Massachusetts General Hospital and is currently Assistant Professor of Obstetrics, Gynecology, and Reproductive Medicine at Harvard Medical School.

His primary clinical and research focus involves development and utilization of minimally invasive surgical techniques in the diagnosis and management of gynecologic cancers.

Dr. Whitfield Growdon was born and raised in Boston. He graduated from Williams College with a degree in Art History. After years of appreciating fine arts in the Berkshire Mountains, he attended the University of Massachusetts Medical School. There he metAmanda, and 5 days before graduation, they were married in Salem, MA.

He returned to Boston where he was a resident atthe integrated Brigham & Womens/MGH Combined OBGYN Residency, and alsocompleted a gynecologic oncology fellowship at the Massachusetts General Hospital.

His interests include minimally invasive surgery and correlative investigationinto rare gynecologic tumors. He lives in downtown Boston with his wife and his 2 year olddaughter Lily who lights up his world.

Dr Birrer is vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS).

Birrer completed his medical degree and doctorate of philosophy in 1982 in the Medical Scientist Training Program at the Albert Einstein College of Medicine in New York. Following a medical internship and residency at Massachusetts General Hospital, Birrer entered the Medical Oncology Fellowship program at the National Cancer Institute in Bethesda, Maryland. After his fellowship, Birrer was appointed senior investigator (with tenure) and established the molecular mechanism section in the Division of Cancer Prevention and Control.

In 2008, Birrer was appointed professor of medicine at the Harvard School of Medicine and assumed the position of director for both Gynecologic Medical Oncology at Massachusetts General Hospital and the Gynecologic Oncology Research Program at the Dana Farber/Harvard Cancer Center.

In 2017, he accepted the position of director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, where he served as professor of medicine, pathology and OB-GYN.

Recognized nationally and internationally as an expert in gynecologic oncology, Birrer’s primary research interest is in characterizing the genomics of gynecologic cancers to improve the clinical management of these diseases. His clinical interests include ovarian cancer, endometrial cancer and cervical cancer.

Birrer has approximately 400 publications, including peer-reviewed manuscripts, book chapters and review articles. He served as chair and chair emeritus of the Department of Defense Ovarian Cancer Research Program, chair of the Committee for Experimental Medicine of the Gynecologic Oncology Group, chair of the Translational Science Working Group of the Gynecologic Cancer Intergroup, and a member of the Gynecologic Cancer Steering Committee.

Nicholas Thomas qualified from the London Hospital in 1988. Following general surgical training he completed the Fellowship of the Royal College of Surgeons FRCS (Glasgow) and FRCS (England) in 1993. He trained in neurosurgery at the Atkinson Morley’s Hospital, Great Ormond Street Hospital for Children and the National Hospital, Queen Square in London in addition to a year’s Spinal Fellowship at Ohio State University, Columbus, Ohio. He completed the FRCS in Surgical Neurology in 1998.

He was appointed a Consultant Neurosurgeon at King’s College Hospital, London in 1998 at the age of 33. With a broad clinical practice, sub-specialty interests include complex spinal surgery, anterior and lateral skull base surgery (including vestibular schwannoma surgery) and endoscopic pituitary and skull base surgery. Within these, he has a particular interest in chordoma, condrosarcoma, basilar invagination, craniopharyngioma and acoustic neuroma.

He runs a national multi-disciplinary dedicated to neurofibromatosis and von Hippel Lindau disease clinic. 

He is widely acknowledged as one of the world’s leading Skull Base surgeons and the pioneer of endoscopic Skull Base surgery in the UK and as such he is UK President of the British Skull Based Society. 

He is a valued panel member on international workshops on endoscopic pituitary surgery (e.g. Guy’s and St Thomas’ and Coventry) as well as ‘open’ lateral skull base surgery (e.g. Copenhagen Skull Base Course).

For the past 22 years he has visited Sri Lanka to lecture and perform operations with local neurosurgeons at the National Hospital and Sri Jayawardenapura Hospital in Colombo on a charitable basis.

Mr Selway has been a Consultant Neurosurgeon since 2001. He studied medicine and neuroanatomy in Cambridge and had specialist training in Birmingham, Cambridge, Oxford and in London where he completed a fellowship in functional neurosurgery. He also gained a first class degree in mathematics and was awarded the Norman Dott Gold Medal by the Royal College of Surgeons in 1999.

As Clinical Director for Neurosciences at King’s College Hospital, he is responsible for one of the largest departments in United Kingdom. Much of his work centres around the use of multidisciplinary teams to ensure the right patient reaches the right clinician. This is particularly important for spinal disorders when both surgical and non-surgical techniques must be combined to obtain the optimum outcome for the individual.

In addition to his expertise in spinal disease, including the management of back, neck and arm pain and sciatica, he specialises in the neurosurgery of epilepsy and movement disorders in both adults and children, with a nationwide as well as international practice for both disorders.

Mr Selway’s research work has focused on the delivery and measurement of high quality patient care through multidisciplinary expertise in a variety of diseases as well as in the techniques of neuro-stimulation in dystonia and epilepsy. He has more than 150 publications.

Mr Malik is a Consultant Neurosurgeon at King’s College Hospital, London with more than 20 years’ experience. He is recognised as a leader in complex spine surgery with specific expertise in minimally invasive, endoscopic, keyhole surgery. He has pioneered several endoscopic spinal procedures, is one of few surgical references for the United Kingdom and has established King’s College Hospital as a training centre for endoscopic spinal surgery, training junior doctors in these procedures.

He completed advanced neurosurgical training at The Royal Hallamshire Hospital and the University Hospital, Coventry & Warwickshire between 2001 - 2006. Following this he obtained his Fellowship of the Royal College of Surgeons (SN) and then enhanced his experience by completing fellowships in complex spine and epilepsy surgery from University Hospital Coventry and King’s College Hospital.

His area of expertise includes the assessment and treatment (both surgical and non-surgical) of all spinal conditions including degenerative, traumatic and malignant spinal surgery. Mr Malik is an expert in the use of minimally invasive techniques for the treatment of neck pain, back pain, arm pain and sciatica.

He is a well-established epilepsy surgeon partaking in the UK Lead Vagal Nerve Stimulator (VNS) Programme. He is part of the International Faculty for Endoscopic and Minimally Invasive Surgery Society for all aspects of spine surgery. He is a member of the International Society for Minimal Intervention in Spinal Surgery (ISMISS), British Association of Spine Surgery (BASS), European Spine Society and North American Spine Society (NASS).

Mr Malik has published several peer review papers, abstracts and book chapters and regularly lectures and teaches in workshops for Minimally Invasive Surgery and Endoscopic Spine Surgery.

Richard Gullan qualified at St. Bartholomew’s Hospital, London and started his surgical career on the Professorial Surgical Unit there before continuing general training to obtain his Membership of the Royal College of Physicians and Fellowship of the Royal College of Surgeons of England. He undertook neurosurgical training in Cambridge, Edinburgh and London prior to being appointed in 1988 as Consultant Neurosurgeon to the SE Thames Regional Neurosurgical Unit at the Brook Hospital, which was amalgamated with the Guy’s/Maudsley Unit to create the King’s College Hospital Neuroscience Centre in 1995, where he is the senior neurosurgeon.

He developed a large practice in spinal and neurovascular surgery and created one of the first multidisciplinary Neuro-Oncology clinics in the NHS and the Private Sector in the UK.

Within the field of spinal neurosurgery he has established a reputation of being at the forefront of many techniques. He presented the first use of posterior instrumented stabilization for malignant disease affecting the spinal column just prior to his appointment as a consultant neurosurgeon and was the first neurosurgeon worldwide to pilot the use of intervertebral fusion cages for cervical disc surgery and the first to introduce posterior lumbar interbody fusion to neurosurgeons in the UK. These techniques have since become commonly employed on an international basis.

He was amongst the first within British neurosurgical practice to employ the use of pedicle screw instrumentation, trans-oral spinal surgery for complex cranio-cervical disorders, percutaneous disc surgery, cervical disc arthroplasty and pioneered surgery under local anaesthesia for spinal decompressive procedures in high risk patients.

Work in these fields has been presented and published widely over 20 years of consultant practice. He continues to have a major interest in the management of brain and spinal tumours and is actively engaged in the introduction of the first Cyberknife Unit in the UK.

Teaching, especially operative technique and clinical decision making to young neurosurgeons has been a much cherished activity and he has been significantly involved in the training of over a dozen senior trainees who have gone on to take up consultant neurosurgical posts in the UK as well as trainees who have been appointed to senior positions abroad.

Mr Chandler has been a Consultant Adult and Paediatric Neurosurgeon since 1997. He has a BSc in Physiology and obtained his medical degree from the University of London (Westminster Medical School) in 1986. His neurosurgical training was in London (Atkinson Morley Hospital, King’s College Hospital), Bristol (Frenchay Hospital) and Nottingham (Queens Medical Centre).

He undertook fellowships in epilepsy surgery (King’s College Hospital) and paediatric neurosurgery (Nottingham). Mr Chandler’s interests are in all aspects of paediatric neurosurgery and neuro-oncology. This includes the management of brain and spinal cord tumours in all age groups, metastatic brain tumours, epilepsy, idiopathic intracranial hypertension and hydrocephalus.

He leads the Paediatric and Adolescent (teenage and young adult) Neurosurgical Service at King’s College Hospital. He is also one of the designated neurosurgeons to the regional Adult Brain and Spinal Cord Tumour Service, which covers South East London, Kent and East Sussex and is the largest brain tumour service in the UK.

He also has a wealth of knowledge in degenerative spine disease including the management of back and neck pain, arm pain and sciatica.

Mr Bhangoo is a Consultant Neurologist with specialist interest in brain tumours, radiosurgery (including CyberKnife) and adult spinal surgery.

Mr Bhangoo qualified Victor Ludorum from medical School with the Medical School Gold Medal and Honours. After his general surgical training (Fellowship of the Royal College of Surgeons, England), his specialist training in neurosurgery was completed on the West Midlands neurosurgical rotation and he was awarded the Norman Dott Gold Medal in Neurosurgery on completion of his training as the highest ranked neurosurgical trainee in the United Kingdom. Following this, Mr Bhangoo spent one year studying both the medical and surgical treatments of brain tumours as well as undertaking research at one of Europe’s leading cancer institute – The Institute Gustauve Roussy, Paris, France.

In addition to his knowledge in all areas of cranial and spinal neurosurgery; including degenerative spine disease which incorporates the management of back and neck pain, arm pain and sciatica together with peripheral nerve disorders such as carpal tunnel syndrome, he has specialist expertise in the management of brain and spinal tumours. This includes the latest minimally invasive techniques for brain tumour removal as well as radiosurgery. He is one of the few neurosurgeons in the UK trained in both GammaKnife and CyberKnife radiosurgery for treating these conditions.

Currently he is Clinical Director for Neuroscience at King’s College Hospital in London and the Neurosurgical Tutor to the European Society for Radiotherapy and Oncology.

Mr Bell specialises in Complex Spinal Surgery. He studied at Merchant Taylor’s School in Liverpool before moving to the University of Edinburgh Medical School where he graduated in 1996. He completed his basic surgical training in Edinburgh before moving to London to complete his higher surgical training in Neurosurgery and Complex Spine surgery.

He became a Member of the Royal College of Surgeons of Edinburgh in 2000 and obtained his Fellowship in Neurosurgery in 2007. He is a member of the British Association of Spinal Surgeons (BASS) where he sits on the executive board as well as the North American Spine Society (NASS). He is the National Lead Elect for the British Spine Registry with responsibility for quality assurance and outcome assessment in spinal surgery. Mr Bell also has national responsibility for the administration of the British Spine Registry. He is the clinical co-lead of South East London and Kent Spinal Network and has been instrumental in the organisation of regional spinal services.

At King’s College Hospital he is a key part of the Supra-Regional Complex Spine Team. His specialisms include degenerative spinal disease, Minimally Invasive Spine Surgery (MISS), disc replacement surgery, vertebroplasty/kyphoplasty, back pain, spinal tumours, metastatic spinal cord compression and spinal fractures.

He lectures nationally and internationally on topics such as back pain, spinal tumours, myelopathy, neck pain and the ageing spine.